“九期一”折戟退市,AD新药“国内报产”

盖德化工网
Aug 01, 2025

虽然“九期一”上市后长期面临疗效争议,但它的销售放量也给业界提了个醒:市场不仅需要疗效有验证的新药,也呼唤兼顾可及性的新药。图源:绿谷医药绿谷医药从停产到裁员,“九期一”断供能否复市未知Guide View上海绿谷医药科技有限公司(下文简称:绿谷)已于2025年7月2日通过全国销售线上会议宣布:‌全国销售岗位员工的最后工作日确定为7月30日‌,仅保留小部分员工支持临床研究项目,其余近八成员工将面临...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10